BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhong P, Xu J, Yang D, Shen Y, Wang L, Feng Y, Du C, Song Y, Wu C, Hu X, Sun Y. COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduct Target Ther 2020;5:256. [PMID: 33139693 DOI: 10.1038/s41392-020-00373-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
Number Citing Articles
1 Shafqat A, Shafqat S, Salameh SA, Kashir J, Alkattan K, Yaqinuddin A. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review. Front Immunol 2022;13:835104. [DOI: 10.3389/fimmu.2022.835104] [Reference Citation Analysis]
2 Yang K, Wen G, Wang J, Zhou S, Da W, Meng Y, Xue Y, Tao L. Complication and Sequelae of COVID-19: What Should We Pay Attention to in the Post-Epidemic Era. Front Immunol 2021;12:711741. [PMID: 34539642 DOI: 10.3389/fimmu.2021.711741] [Reference Citation Analysis]
3 Kgatle MM, Lawal IO, Mashabela G, Boshomane TMG, Koatale PC, Mahasha PW, Ndlovu H, Vorster M, Rodrigues HG, Zeevaart JR, Gordon S, Moura-Alves P, Sathekge MM. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks. Front Immunol 2021;12:752380. [PMID: 34691068 DOI: 10.3389/fimmu.2021.752380] [Reference Citation Analysis]
4 Sweed D, El Shanshory MR, Elaskary EM, Hassan HA, Sweed E, Sweed E, Abdelsattar S, Abdelgawad A, Mosbeh A, Abdallah H, El-Mashad S, Ehsan N. Trichrome-positive intrahepatic cytoplasmic globules are potential histopathological clue for COVID-19-induced hepatitis: a case report. Egypt Liver J 2021;11:69. [PMID: 34777872 DOI: 10.1186/s43066-021-00140-5] [Reference Citation Analysis]
5 Settanni CR, Ianiro G, Ponziani FR, Bibbò S, Segal JP, Cammarota G, Gasbarrini A. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms. World J Gastroenterol 2021; 27(43): 7433-7445 [PMID: 34887641 DOI: 10.3748/wjg.v27.i43.7433] [Reference Citation Analysis]
6 Bozkurt HS, Bilen Ö. Gastrointestinal symptoms in COVID-19 could be associated with severe lung involvement and increased readmission rates. Eur J Inflamm 2021;19:205873922110482. [DOI: 10.1177/20587392211048259] [Reference Citation Analysis]
7 Al-Nimer MS. Is COVID-19-induced liver injury different from other RNA viruses?‎ World J Meta-Anal 2021; 9(2): 108-127 [DOI: 10.13105/wjma.v9.i2.108] [Reference Citation Analysis]
8 Spolidoro GCI, Azzolino D, Shamir R, Cesari M, Agostoni C. Joint Effort towards Preventing Nutritional Deficiencies at the Extremes of Life during COVID-19. Nutrients 2021;13:1616. [PMID: 34065864 DOI: 10.3390/nu13051616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xu Y, Yang X, Bian H, Xia M. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management. Lipids Health Dis 2021;20:126. [PMID: 34602072 DOI: 10.1186/s12944-021-01564-z] [Reference Citation Analysis]
10 Sridhar S, Nicholls J. Pathophysiology of infection with SARS-CoV-2-What is known and what remains a mystery. Respirology 2021;26:652-65. [PMID: 34041821 DOI: 10.1111/resp.14091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Chinnici CM, Russelli G, Bulati M, Miceli V, Gallo A, Busà R, Tinnirello R, Conaldi PG, Iannolo G. Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment. World J Gastroenterol 2021; 27(17): 1905-1919 [PMID: 34007129 DOI: 10.3748/wjg.v27.i17.1905] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Meng XJ, Liang TJ. SARS-CoV-2 Infection in the Gastrointestinal Tract: Fecal-Oral Route of Transmission for COVID-19? Gastroenterology 2021;160:1467-9. [PMID: 33422479 DOI: 10.1053/j.gastro.2021.01.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World J Clin Cases 2021; 9(22): 6178-6200 [PMID: 34434987 DOI: 10.12998/wjcc.v9.i22.6178] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kolesova O, Vanaga I, Laivacuma S, Derovs A, Kolesovs A, Radzina M, Platkajis A, Eglite J, Hagina E, Arutjunana S, Putrins DS, Storozenko J, Rozentale B, Viksna L. Intriguing findings of liver fibrosis following COVID-19. BMC Gastroenterol 2021;21:370. [PMID: 34635073 DOI: 10.1186/s12876-021-01939-7] [Reference Citation Analysis]
15 Ghazanfar H, Kandhi S, Shin D, Muthumanickam A, Gurjar H, Qureshi ZA, Shaban M, Farag M, Haider A, Budhathoki P, Bhatt T, Ghazanfar A, Jyala A, Patel H. Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review. Cureus. [DOI: 10.7759/cureus.23333] [Reference Citation Analysis]
16 Wang MK, Yue HY, Cai J, Zhai YJ, Peng JH, Hui JF, Hou DY, Li WP, Yang JS. COVID-19 and the digestive system: A comprehensive review. World J Clin Cases 2021; 9(16): 3796-3813 [PMID: 34141737 DOI: 10.12998/wjcc.v9.i16.3796] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
17 Loinaz-Segurola C, Marcacuzco-Quinto A, Fernández-Ruiz M. Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects. World J Hepatol 2021; 13(10): 1299-1315 [PMID: 34786167 DOI: 10.4254/wjh.v13.i10.1299] [Reference Citation Analysis]
18 Su YJ, Chang CW, Chen MJ, Lai YC. Impact of COVID-19 on liver. World J Clin Cases 2021; 9(27): 7998-8007 [PMID: 34621856 DOI: 10.12998/wjcc.v9.i27.7998] [Reference Citation Analysis]
19 Wang MK, Yu XL, Zhou LY, Si HM, Hui JF, Hou DY, Li WP, Yang JS. COVID-19 and liver dysfunction: What nutritionists need to know. World J Gastroenterol 2022; 28(15): 1526-1535 [DOI: 10.3748/wjg.v28.i15.1526] [Reference Citation Analysis]
20 Lazova S, Alexandrova T, Gorelyova-Stefanova N, Atanasov K, Tzotcheva I, Velikova T. Liver Involvement in Children with COVID-19 and Multisystem Inflammatory Syndrome: A Single-Center Bulgarian Observational Study. Microorganisms 2021;9:1958. [PMID: 34576853 DOI: 10.3390/microorganisms9091958] [Reference Citation Analysis]
21 Madhu D, Sharma S, Agarwal A, Saraya A. Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review. J Clin Transl Hepatol 2021;9:568-75. [PMID: 34447687 DOI: 10.14218/JCTH.2021.00001] [Reference Citation Analysis]
22 Trougakos IP, Stamatelopoulos K, Terpos E, Tsitsilonis OE, Aivalioti E, Paraskevis D, Kastritis E, Pavlakis GN, Dimopoulos MA. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications. J Biomed Sci 2021;28:9. [PMID: 33435929 DOI: 10.1186/s12929-020-00703-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
23 Eldokla AM, Mohamed-Hussein AA, Fouad AM, Abdelnaser MG, Ali ST, Makhlouf NA, Sayed IG, Makhlouf HA, Shah J, Aiash H. Prevalence and patterns of symptoms of dysautonomia in patients with long-COVID syndrome: A cross-sectional study. Ann Clin Transl Neurol 2022. [PMID: 35393771 DOI: 10.1002/acn3.51557] [Reference Citation Analysis]
24 Yusuf F, Fahriani M, Mamada SS, Frediansyah A, Abubakar A, Maghfirah D, Fajar JK, Maliga HA, Ilmawan M, Emran TB, Ophinni Y, Innayah MR, Masyeni S, Ghouth ASB, Yusuf H, Dhama K, Nainu F, Harapan H. Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis. F1000Res 2021;10:301. [PMID: 34131481 DOI: 10.12688/f1000research.52216.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Reference Citation Analysis]
26 Gomides APM, de Albuquerque CP, da Mota LMH, Devidé G, Dias LH, Duarte ALBP, Giovelli RA, Karnopp TE, de Lima HD, Marinho A, de Oliveira MS, Omura F, Ranzolin A, Resende G, Ribeiro FM, Ribeiro SLE, de Carvalho Sacilotto N, Dos Santos WG, Shinjo SK, de Sousa Studart SA, Teixeira FPS, Yazbek MA, Ferreira GA, Monticielo OA, Paiva E, Pileggi GCS, Dos Reis-Neto ET, de Medeiros Pinheiro M, Marques CDL; ReumaCoV Brasil Registry. Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry. Adv Rheumatol 2022;62:13. [PMID: 35505408 DOI: 10.1186/s42358-022-00244-5] [Reference Citation Analysis]
27 Townsend L, Dyer AH, Naughton A, Imangaliyev S, Dunne J, Kiersey R, Holden D, Mooney A, Leavy D, Ridge K, Sugrue J, Aldoseri M, Kelliher JH, Hennessy M, Byrne D, Browne P, Bacon CL, Doyle C, O’riordan R, Mclaughlin A, Bannan C, Martin-loeches I, White A, Mcloughlin RM, Bergin C, Bourke NM, O’farrelly C, Conlon N, Cheallaigh CN. Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression. Heliyon 2022;8:e09230. [DOI: 10.1016/j.heliyon.2022.e09230] [Reference Citation Analysis]
28 Alkattan W, Yaqinuddin A, Shafqat A, Kashir J. NET-Mediated Pathogenesis of COVID-19: The Role of NETs in Hepatic Manifestations. Journal of Health and Allied Sciences NU. [DOI: 10.1055/s-0041-1741418] [Reference Citation Analysis]
29 Cherneva R, Cherneva Z. Long COVID-19 Syndrome: Multiorgan Damage and Recommendations for Follow-Up and Rehabilitation. Acta Medica Bulgarica 2022;49:57-62. [DOI: 10.2478/amb-2022-0010] [Reference Citation Analysis]
30 Tafreshi S, Whiteside I, Levine I, D'Agostino C. A case of secondary sclerosing cholangitis due to COVID-19. Clin Imaging 2021;80:239-42. [PMID: 34364072 DOI: 10.1016/j.clinimag.2021.07.017] [Reference Citation Analysis]
31 Vitrone M, Mele F, Durante-Mangoni E, Zampino R. Drugs and liver injury: a not to be overlooked binomial in COVID-19. J Chemother 2021;:1-14. [PMID: 34644236 DOI: 10.1080/1120009X.2021.1988203] [Reference Citation Analysis]
32 Brady M, McQuaid C, Solorzano A, Johnson A, Combs A, Venkatraman C, Rahman A, Leyva H, Kwok WE, Wood RW, Deane R. Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2. Commun Biol 2021;4:1318. [PMID: 34811493 DOI: 10.1038/s42003-021-02856-x] [Reference Citation Analysis]
33 Rezkalla SH, Kloner RA. Post-Acute Sequelae of SARS-COVID-2 Syndrome: Just the Beginning. Cardiol Res 2021;12:279-85. [PMID: 34691325 DOI: 10.14740/cr1290] [Reference Citation Analysis]
34 Majidpoor J, Mortezaee K. Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications. Biomed Pharmacother 2021;145:112419. [PMID: 34781146 DOI: 10.1016/j.biopha.2021.112419] [Reference Citation Analysis]
35 Clarysse M, Ceulemans LJ, Wauters L, Gilbo N, Capiau V, De Hertogh G, Laleman W, Verslype C, Monbaliu D, Pirenne J, Vanuytsel T. Potential importance of early treatment of SARS-CoV-2 infection in intestinal transplant patient: A case report. World J Transplant 2022; 12(4): 72-78 [DOI: 10.5500/wjt.v12.i4.72] [Reference Citation Analysis]
36 Daemi HB, Kulyar MF, He X, Li C, Karimpour M, Sun X, Zou Z, Jin M. Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies. Viruses 2021;13:1145. [PMID: 34203647 DOI: 10.3390/v13061145] [Reference Citation Analysis]
37 Peng XL, Cheng JS, Gong HL, Yuan MD, Zhao XH, Li Z, Wei DX. Advances in the design and development of SARS-CoV-2 vaccines. Mil Med Res 2021;8:67. [PMID: 34911569 DOI: 10.1186/s40779-021-00360-1] [Reference Citation Analysis]
38 Dhakal J, Jia M, Joyce JD, Moore GA, Ovissipour R, Bertke AS. Survival of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Herpes Simplex Virus 1 (HSV-1) on Foods Stored at Refrigerated Temperature. Foods 2021;10:1005. [PMID: 34064494 DOI: 10.3390/foods10051005] [Reference Citation Analysis]
39 Cheng C, Huang Y, Xie L, Zhu X, Chen D, Cheng C. Therapy of diarrhea in COVID-19 with external treatment of traditional Chinese medicine: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24120. [PMID: 33429783 DOI: 10.1097/MD.0000000000024120] [Reference Citation Analysis]
40 Wang RR, He M, Kang Y. A risk score based on procalcitonin for predicting acute kidney injury in COVID-19 patients. J Clin Lab Anal 2021;35:e23805. [PMID: 34032326 DOI: 10.1002/jcla.23805] [Reference Citation Analysis]
41 Yan Z, Yang M, Lai CL. Long COVID-19 Syndrome: A Comprehensive Review of Its Effect on Various Organ Systems and Recommendation on Rehabilitation Plans. Biomedicines 2021;9:966. [PMID: 34440170 DOI: 10.3390/biomedicines9080966] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 13.0] [Reference Citation Analysis]
42 Dai Y, Zhao Z, Zhou H, Huang D, Luo J, Zhang C, Chen Q, Chen X, Yao Y, Jiang X, Cheng J. Traditional Chinese Medicine Enema Therapy in a Patient With a Confirmed Negative SARS-CoV-2 Test in the Respiratory Tract but Positive in the Intestinal Tract: A Case Report. Front Public Health 2021;9:687283. [PMID: 34307281 DOI: 10.3389/fpubh.2021.687283] [Reference Citation Analysis]
43 Chew M, Tang Z, Radcliffe C, Caruana D, Doilicho N, Ciarleglio MM, Deng Y, Garcia-Tsao G. Significant Liver Injury During Hospitalization for COVID-19 Is Not Associated With Liver Insufficiency or Death. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00525-5. [PMID: 34004326 DOI: 10.1016/j.cgh.2021.05.022] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
44 Deane K, Singh A, Sarfraz A, Sarfraz Z, Ciccone L, Zheng B, Afzal A, Khan G, Rodriguez G, Bahtiyar G. Correlation of Severity of COVID-19 Disease With Gastrointestinal Manifestations and Liver Injury - A North Brooklyn Community Hospital Experience: A Retrospective Cohort Study. Cureus 2021;13:e14543. [PMID: 34017658 DOI: 10.7759/cureus.14543] [Reference Citation Analysis]
45 Rahban M, Stanek A, Hooshmand A, Khamineh Y, Ahi S, Kazim SN, Ahmad F, Muronetz V, Samy Abousenna M, Zolghadri S, Saboury AA. Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients. J Clin Med 2021;10:4802. [PMID: 34768321 DOI: 10.3390/jcm10214802] [Reference Citation Analysis]
46 Shousha HI, Afify S, Maher R, Asem N, Fouad E, Mostafa EF, Medhat MA, Abdalazeem A, Elmorsy H, Aziz MM, Mohammed RS, Ibrahem M, Elgarem H, Omran D, Hassany M, Elsayed B, Abdelaziz AY, El Kassas M. Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study. World J Gastroenterol 2021; 27(40): 6951-6966 [PMID: 34790017 DOI: 10.3748/wjg.v27.i40.6951] [Reference Citation Analysis]
47 Murgolo N, Therien AG, Howell B, Klein D, Koeplinger K, Lieberman LA, Adam GC, Flynn J, McKenna P, Swaminathan G, Hazuda DJ, Olsen DB. SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development. PLoS Pathog 2021;17:e1009225. [PMID: 33596266 DOI: 10.1371/journal.ppat.1009225] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 30.0] [Reference Citation Analysis]
48 He J, Yang L, Tao Z, Yang J, Zhou Y, Wang R, Zhang Y, Huang Y, Zhou L, Sun B, Gao J. Impact of the 2019 Novel Coronavirus Disease (COVID-19) Epidemic on Radiotherapy-Treated Patients with Cancer: A Single-Center Descriptive Study. Cancer Manag Res 2021;13:37-43. [PMID: 33442292 DOI: 10.2147/CMAR.S281323] [Reference Citation Analysis]
49 Quan Y, Li L, Yin Z, Chen S, Yi J, Lang J, Zhang L, Yue Q, Zhao J. Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19? Front Pharmacol 2022;12:784335. [DOI: 10.3389/fphar.2021.784335] [Reference Citation Analysis]
50 Sweed D, Abdelsameea E, Khalifa EA, Abdallah H, Moaz H, Moaz I, Abdelsattar S, Abdel-Rahman N, Mosbeh A, Elmahdy HA, Sweed E. SARS-CoV-2-associated gastrointestinal and liver diseases: what is known and what is needed to explore. Egypt Liver J 2021;11:64. [PMID: 34777871 DOI: 10.1186/s43066-021-00123-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 O'Donnell JS, Chappell KJ. Chronic SARS-CoV-2, a Cause of Post-acute COVID-19 Sequelae (Long-COVID)? Front Microbiol 2021;12:724654. [PMID: 34408742 DOI: 10.3389/fmicb.2021.724654] [Reference Citation Analysis]
52 Liemarto AK, Budiono BP, Chionardes MA, Oliviera I, Rahmasiwi A. Liver abscess with necrosis in post COVID-19: A case report. Ann Med Surg (Lond) 2021;72:103107. [PMID: 34840781 DOI: 10.1016/j.amsu.2021.103107] [Reference Citation Analysis]
53 Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, Ribeiro da Silveira P, Tiwari S, Alzahrani KJ, Góes-Neto A, Azevedo V, Ghosh P, Barh D. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses 2021;13:700. [PMID: 33919537 DOI: 10.3390/v13040700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
54 Patel RK, Chandel K, Mittal S, Tripathy T. Abdominal Computed Tomography Findings among COVID-19 Patients with Index Gastrointestinal Manifestations: A Preliminary Single-center Experience. Euroasian J Hepatogastroenterol 2021;11:76-80. [PMID: 34786360 DOI: 10.5005/jp-journals-10018-1346] [Reference Citation Analysis]
55 Maza MDC, Úbeda M, Delgado P, Horndler L, Llamas MA, van Santen HM, Alarcón B, Abia D, García-bermejo L, Serrano-villar S, Bastolla U, Fresno M. ACE2 Serum Levels as Predictor of Infectability and Outcome in COVID-19. Front Immunol 2022;13:836516. [DOI: 10.3389/fimmu.2022.836516] [Reference Citation Analysis]
56 Omar AS, Kaddoura R, Orabi B, Hanoura S. Impact of COVID-19 pandemic on liver, liver diseases, and liver transplantation programs in intensive care units. World J Hepatol 2021; 13(10): 1215-1233 [PMID: 34786163 DOI: 10.4254/wjh.v13.i10.1215] [Reference Citation Analysis]
57 Marongiu L, Valache M, Facchini FA, Granucci F. How dendritic cells sense and respond to viral infections. Clin Sci (Lond) 2021;135:2217-42. [PMID: 34623425 DOI: 10.1042/CS20210577] [Reference Citation Analysis]
58 Pott-Junior H, Bittencourt NQP, Chacha SFG, Luporini RL, Cominetti MR, Anibal FF. Elevations in Liver Transaminases in COVID-19: (How) Are They Related? Front Med (Lausanne) 2021;8:705247. [PMID: 34336904 DOI: 10.3389/fmed.2021.705247] [Reference Citation Analysis]
59 Heuberger J, Trimpert J, Vladimirova D, Goosmann C, Lin M, Schmuck R, Mollenkopf HJ, Brinkmann V, Tacke F, Osterrieder N, Sigal M. Epithelial response to IFN-γ promotes SARS-CoV-2 infection. EMBO Mol Med 2021;13:e13191. [PMID: 33544398 DOI: 10.15252/emmm.202013191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
60 Su YJ, Chang CW, Chen MJ, Lai YC. Impact of COVID-19 on liver. World J Clin Cases 2021;9:7998-8007. [PMID: 34621856 DOI: 10.12998/wjcc.v9.i27.7998] [Reference Citation Analysis]
61 Karna ST, Singh P, Revadi G, Khurana A, Shivhare A, Saigal S, Rathiswamy MK, Sharma JP, Waindeskar V. Frequency and Impact of Preadmission Digestive Symptoms on Outcome in Severe COVID-19: A Prospective Observational Cohort Study. Indian J Crit Care Med 2021;25:1247-57. [PMID: 34866821 DOI: 10.5005/jp-journals-10071-24020] [Reference Citation Analysis]
62 Romero-Duarte Á, Rivera-Izquierdo M, Guerrero-Fernández de Alba I, Pérez-Contreras M, Fernández-Martínez NF, Ruiz-Montero R, Serrano-Ortiz Á, González-Serna RO, Salcedo-Leal I, Jiménez-Mejías E, Cárdenas-Cruz A. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med 2021;19:129. [PMID: 34011359 DOI: 10.1186/s12916-021-02003-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
63 Lin P, Chen W, Huang H, Lin Y, Cai M, Lin D, Cai H, Su Z, Zhuang X, Yu X. Delayed discharge is associated with higher complement C3 levels and a longer nucleic acid-negative conversion time in patients with COVID-19. Sci Rep 2021;11:1233. [PMID: 33441900 DOI: 10.1038/s41598-021-81010-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
64 Wang J, Zhu K, Xue Y, Wen G, Tao L. Research Progress in the Treatment of Complications and Sequelae of COVID-19. Front Med (Lausanne) 2021;8:757605. [PMID: 34926504 DOI: 10.3389/fmed.2021.757605] [Reference Citation Analysis]
65 Ristic-Medic D, Petrovic S, Arsic A, Vucic V. Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition. World J Gastroenterol 2021; 27(34): 5682-5699 [PMID: 34629794 DOI: 10.3748/wjg.v27.i34.5682] [Reference Citation Analysis]